MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..4 of 4 - per page
Order by
Fenofibrate 160 mg tablet
Generic dossier More
Use of LCAT to Reduce Cholesterol and Prevent Atherosclerosis
A method of decreasing accumulation of cholesterol in arteries of humans by administering lecithin-cholesterol acyltransferase (LCAT). More
ARVI, a protein involved in sterol uptake and sterol homeostasis in the budding yeast, S-cerevisiae, and a functional human ARV
Name of the inventor: Stephen L. Sturley Isolated nucleic acid molecules encoding human and yeast ACAT-Related Enzyme 2 required for viability protein (ARV1p) and the purified forms of the said proteins are described. Method for identifying a chemical... More
Plasma Phospholipid Transfer Protein: a New Target for the Treatment of Atherosclerosis and Dyslipidemia
Lead Inventors: Xian-Cheng Jiang, Ph.D. and Alan R. Tall, Ph.D. Problem or Unmet Need: Cardiovascular disease has been the leading causes of illness in the U.S. for many decades. Atherosclerosis alone affects over 4.5 million people. Characterized by... More
Displaying 1..4 of 4 - per page
Order by

Your selection

Therapeutic target
Cardiovascular del
Blood composition del
Dyslipidemia del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us